Epigenetic changes are regarded as emerging major players for hematopoietic stem cell (HSC) biology. Although some histone deacetylase (HDAC) inhibitors, such as valproic acid (VA), induce differentiation and apoptosis in a variety of leukemic cells in vitro, they produce a favorable effect on the expansion of normal HSCs. In this study, we have identified the VA target HDAC3 as a negative regulator of umbilical cord blood HSC expansion. We demonstrate that knockdown of the transcript dramatically improves CD34+ cell expansion, which correlates with a higher potential to generate colony-forming units in functional assays. We show that this effect is mediated at the level of primitive hematopoietic cells and that it is not due to negative effects on specific cell commitment or alterations in the cell cycle. HDAC3 inhibition does not block commitment to the monocytic lineage and the maturation of monocyte precursors, which are the main inhibited pathways in the presence of VA. Therefore, our results identify HDAC3 as a promising target for therapies aiming to expand HSCs.
Get full access to this article
View all access options for this article.
References
1.
ConneallyE, CashmanJ, PetzerA, EavesC. 1997. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic–scid/scid mice. Proc Natl Acad Sci (USA), 94:9836.
2.
KellySS, SolaCB, de LimaM, ShpallE. 2009. Ex vivo expansion of cord blood. Bone Marrow Transplant, 44:673–681.
3.
MetcalfD. 2007. Concise review: hematopoietic stem cells and tissue stem cells: current concepts and unanswered questions. Stem Cells, 25:2390–2395.
4.
IshikawaF, YasukawaM, LyonsB, YoshidaS, MiyamotoT, YoshimotoG, WatanabeT, AkashiK, ShultzLD, HaradaM. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chainnull mice. Blood, 106:1565.
5.
MajetiR, ParkCY, WeissmanIL. 2007. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell, 1:635–645.
6.
VanheusdenK, Van CoppernolleS, De SmedtM, PlumJ, VandekerckhoveB. 2007. In vitro expanded cells contributing to rapid severe combined immunodeficient repopulation activity are CD34+38-33+90+45RA. Stem Cells, 25:107–114.
7.
BugG, GulH, SchwarzK, PfeiferH, KampfmannM, ZhengX, BeissertT, BoehrerS, HoelzerD, OttmannOG, RuthardtM. 2005. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res, 65:2537–2541.
8.
De FeliceL, TatarelliC, MascoloMG, GregorjC, AgostiniF, FioriniR, GelmettiV, PascaleS, PadulaFet al.2005. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res, 65:1505–1513.
9.
TunnicliffG. 1999. Actions of sodium valproate on the central nervous system. J Physiol Pharmacol, 50:347–365.
10.
JohannessenCU. 2000. Mechanisms of action of valproate: a commentatory. Neurochem Int, 37:103–110.
11.
SantiniV, GozziniA, FerrariG. 2007. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr Drug Metab, 8:383–393.
Santos-RosaH, CaldasC. 2005. Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer, 41:2381–2402.
14.
DavieJR, SpencerVA. 2001. Signal transduction pathways and the modification of chromatin structure. Prog Nucleic Acid Res Mol Biol, 65:299–340.
15.
HuangW, ZhaoS, AmmanamanchiS, BrattainM, VenkatasubbaraoK, FreemanJW. 2005. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. J Biol Chem, 280:10047–10054.
16.
LuoJ, LiM, TangY, LaszkowskaM, RoederRG, GuW. 2004. Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci (USA), 101:2259–2264.
17.
MarzioG, WagenerC, GutierrezMI, CartwrightP, HelinK, GiaccaM. 2000. E2F family members are differentially regulated by reversible acetylation. J Biol Chem, 275:10887–10892.
Carcamo-OriveI, GaztelumendiA, DelgadoJ, TejadosN, DorronsoroA, Fernandez-RuedaJ, PenningtonDJ, TriguerosC. 2010. Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk. J Bone Miner Res, 25:2115–2125.
20.
IshizukaT, LazarMA. 2003. The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol Cell Biol., 23:5122.
21.
DoulatovS, NottaF, EppertK, NguyenLT, OhashiPS, DickJE. 2010. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol, 11:585–593.
22.
MayaniH, DragowskaW, LansdorpPM. 1993. Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines. Blood, 82:2664–2672.
23.
MayaniH, DragowskaW, LansdorpPM. 1993. Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells. Blood, 81:3252–3258.
NakamuraY, AndoK, CharguiJ, KawadaH, SatoT, TsujiT, HottaT, KatoS. 1999. Ex vivo generation of CD34(+) cells from CD34(−) hematopoietic cells. Blood, 94:4053–4059.
26.
DanetGH, LeeHW, LuongoJL, SimonMC, BonnetDA. 2001. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion. Exp Hematol, 29:1465–1473.
27.
ShihCC, HuMC, HuJ, MedeirosJ, FormanSJ. 1999. Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. Blood, 94:1623–1636.
SeetLF, TengE, LaiYS, LaningJ, KrausM, WnendtS, MerchavS, ChanSL. 2009. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions. Eur J Haematol, 82:124–132.
30.
DonaldsonC, Denning-KendallP, BradleyB, HowsJ. 2001. The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function. Bone Marrow Transplantat, 27:365–371.
31.
DorrellC, GanOI, PereiraDS, HawleyRG, DickJE. 2000. Expansion of human cord blood CD34(+)CD38(−) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood, 95:102–110.
32.
SzulcJ, WiznerowiczM, SauvainMO, TronoD, AebischerP. 2006. A versatile tool for conditional gene expression and knockdown. Nat Methods, 3:109–116.
33.
ChaurasiaP, BerenzonD, HoffmanR. 2011. Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells. Blood, 117:4632–4641.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
